Delivery Order SPE2DB25D3022-SPE2DB25FWBCW

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,251.41, is a delivery order for the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with a completion date of February 13, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,540.65, is for the delivery of the drug Wegovy 1 mg/0.5 ml pen in 0.5 ml quantities. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 11, 2025. This award is not associated with a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.25, is for the delivery of Wegovy 1 mg/0.5 ml pens. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,787.18, is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside and was awarded on April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,191.20, is for the supply of the drug Wegovy 0.5 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen in 0.5 ml quantities. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 31, 2024. The contract does not have a set-aside designation, indicating open competition. In addition to this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,163.99, is for the delivery of Wegovy 0.25 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a final completion date of February 10, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.60, is for the supply of the prescription medication Wegovy 0.5 mg/0.5 ml pen with an ultimate completion date of March 29, 2023. The contract is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Wegovy 0.25 mg/0.5 ml pen 0.5 ml. The contract has a firm fixed price, with a ceiling value of $6,142.50, and an ultimate completion date of May 16, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the drug Wegovy, a 0.5 mg/0.5 ml pen with a 0.5 ml dosage. The contract is a Delivery Order with a Firm Fixed Price of $7,147.15 and has an Ultimate Completion Date of December 18, 2024. The contract is not designated as a Set-Aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB25D3022
    Indefinite Delivery Contract
  • SPE2DB25D3022-SPE2DB25FWBCW
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,484.00, is for the delivery of the medication Wegovy 0.5 mg/0.5 ml pen. It is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/11/25, 9:55 AM